REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
01/17/2026
Back to search
Official data from USPTO
LONSURF
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
62
Latest update
01/18/2026
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
10/22/2015
Registration date
01/17/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/04/2024
Last transaction
01/18/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
Tokyo, JP
Examiner
THOMAS,JULIE
Law office
L70
Mark description
The mark consists of the wording "LONSURF" in red appearing below two curvy lines, the left one in red and the right curve in red, orange and yellow.
Holders and representatives
Holders
TAIHO PHARMACEUTICAL CO., LTD.
TAIHO PHARMACEUTICAL CO., LTD.
Representatives
Dionne D. Heard Osha Bergman Watanabe & Burton LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsanti-cancer agentsanti-tumor agentsanti-ulcerogenic agentsagents for treatment of immunological diseasesagents for the treatment of urinary diseasesagents for painantiemetic agents; diagnostic agentspreparations and substances for medical purposes; preparations for detecting genetic predispositions for medical purposes; chemical reagents for medical or veterinary purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; capsules sold empty for pharmaceuticals; eyepatches for medical use; ear bandages; menstruation bandages; sanitary tampons; sanitary napkins; sanitary panties; cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; antiseptic liquid bandages; breast-nursing pads; dental adhesives; dental amalgams; dental cements; dental ceramics; dental polish; dental veneers; material for dental fillings and dental impressions; dental composite materials; dental impression materials; dental restoration compounds; sealing agents for dental purposes; lacteal flour for babies; dietary supplements for humans; dietetic foodsbiscuitjellysoup adapted for medical use; beverages for babies; food for babies
Class 42
Scientific research for medical purposes in the field of cancertumorsulcerationimmunological diseasesurinary diseasesnauseavomiting and pain; testinginspectionresearch or evaluation of pharmaceuticals; advisoryconsultancy or information services relating to testinginspectionresearch or evaluation of pharmaceuticals and medicines; testinginspectionresearch or evaluation of medicinepharmaceutical preparationsclinical medical trials; advisoryconsultancy or information services relating to testinginspectionresearch or evaluation of medicinepharmaceutical preparationsclinical medical trials; medical and scientific researchconducting clinical trials for medicine; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; design and development of computer hardware and software for use in the field of medicine; research and development of medical technology; providing information about medical and scientific research in the field of pharmaceuticals; scientific research for medical purposes in the area of cancerous diseases; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; computer programming for the medical sector
Class 44
Medical diagnostic testing in the fields of cancertumorsulcerationimmunological diseasesurinary diseasesnauseavomiting and pain; providing medical information relating to the treatment or prevention of cancertumorsulcerationimmunological diseasesurinary diseasesnauseavomiting and pain; medical consultation services relating to the treatment and diagnosis of cancertumorsulcerationimmunological diseasesurinary diseasesnauseavomiting and pain; medical counseling services relating to the treatment of cancertumorsulcerationimmunological diseasesurinary diseasesnauseavomiting and pain; genetic testing for medical purposesfor the diagnosis and prognosis of the expected progression of cancertumorsulcerationimmunological diseasesurinary diseasesnauseavomiting and pain; providing medical information relating to the efficacyside effectsinteractions of pharmaceuticals and medications; medical services; providing medical information; physical examination; dentistry; preparation and dispensing of medications; medical analysis services for the diagnosis of cancer; medical information services provided via the Internet; providing medical informationconsultancy and advisory services; providing information to patients in the field of administering medication; dietetic advisory services; health care services for treating cancer
Publications
History of USPTO decisions and trademark events.
62 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/25/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/21/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
12/21/2024
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
11/22/2024
INPC
INVALIDATION PROCESSED
11/22/2024
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/05/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/16/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/16/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/16/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/16/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/16/2024
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
03/04/2024
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
03/04/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/26/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/09/2024
ES75
TEAS SECTION 71 & 15 RECEIVED
06/15/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/26/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/26/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/26/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/17/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/27/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/27/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/27/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/27/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/27/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/27/2021
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
11/01/2019
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
10/11/2019
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
01/28/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/24/2019
ES7R
TEAS SECTION 7 REQUEST RECEIVED
12/14/2018
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/15/2018
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
05/13/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/21/2017
FIMP
FINAL DISPOSITION PROCESSED
04/21/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/17/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
01/17/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/01/2016
PUBO
PUBLISHED FOR OPPOSITION
11/01/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/12/2016
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
09/26/2016
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/23/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
09/16/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/16/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
09/16/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/16/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/31/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/31/2016
RFNT
REFUSAL PROCESSED BY IB
05/13/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/18/2016
RFRR
REFUSAL PROCESSED BY MPU
03/18/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/18/2016
CNRT
NON-FINAL ACTION WRITTEN
03/17/2016
MAFR
APPLICATION FILING RECEIPT MAILED
03/04/2016
DOCK
ASSIGNED TO EXAMINER
02/29/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/29/2016
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
02/26/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/25/2016
Continuous trademark protection
Get notified about every new filing that threatens LONSURF or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.